Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) closed the day trading at $2.52 down -6.32% from the previous closing price of $2.69. In other words, the price has decreased by -$6.32 from its previous closing price. On the day, 3.43 million shares were traded.
Ratios:
For a better understanding of MREO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.10 and its Current Ratio is at 6.10. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on December 06, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On June 13, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 13 ’24 when Scots-Knight Denise sold 60,046 shares for $4.22 per share. The transaction valued at 253,454 led to the insider holds 808,921 shares of the business.
Scots-Knight Denise sold 28,611 shares of MREO for $127,968 on Sep 12 ’24. The Chief Executive Officer now owns 868,967 shares after completing the transaction at $4.47 per share. On Sep 13 ’24, another insider, Lewicki John A., who serves as the Chief Scientific Officer of the company, sold 10,937 shares for $4.22 each. As a result, the insider received 46,165 and left with 78,630 shares of the company.
Stock Price History:
Over the past 52 weeks, MREO has reached a high of $5.02, while it has fallen to a 52-week low of $2.53. The 50-Day Moving Average of the stock is -21.48%, while the 200-Day Moving Average is calculated to be -32.88%.
Shares Statistics:
A total of 154.73M shares are outstanding, with a floating share count of 142.29M. Insiders hold about 8.04% of the company’s shares, while institutions hold 66.46% stake in the company.
